​

ACADIA Pharmaceuticals Ownership | Who Owns ACADIA Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

ACADIA Pharmaceuticals Ownership Summary

ACADIA Pharmaceuticals is owned by 55.05% institutional investors, 0.33% insiders, and 44.62% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 25.33% of ACAD shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.46% of its assets in ACADIA Pharmaceuticals shares.

ACAD Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockACADIA Pharmaceuticals55.05%0.33%44.62%
SectorHealthcare Stocks 35.49%11.75%52.76%
IndustryBiotech Stocks 34.83%11.71%53.46%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp42.90M25.33%$954.88M
Blackrock funding, inc. /de21.55M12.73%$479.72M
Vanguard group15.15M8.98%$404.76M
Blackrock12.06M7.32%$196.01M
State street8.33M4.92%$185.49M
Rtw investments, lp7.14M4.22%$159.04M
Geode capital management3.46M2.05%$77.14M
First trust advisors lp3.34M1.97%$74.43M
Dimensional fund advisors lp3.16M1.86%$70.22M
Palo alto investors lp2.87M1.70%$63.95M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Palo alto investors lp2.87M9.78%$63.95M
Baker bros. advisors lp42.90M5.48%$954.88M
Axecap investments152.91K2.34%$3.40M
Birchview capital, lp171.00K2.17%$3.81M
Nan fung group102.98K1.89%$2.29M
Braidwell lp2.47M1.83%$55.01M
Verdad advisers, lp68.29K1.71%$1.52M
Rtw investments, lp7.14M1.58%$159.04M
Stempoint capital lp242.57K1.05%$5.40M
Sphera funds management256.20K0.91%$5.70M

Top Buyers

HolderShares% AssetsChange
Norges bank1.51M0.00%1.51M
Artisan partners limited partnership1.33M0.05%1.33M
First trust advisors lp3.34M0.05%1.07M
Vanguard fiduciary trust875.72K0.01%875.72K
Jane street group803.26K0.00%803.26K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---1.35M
Finepoint capital lp---905.38K
Point72 asset management2.58M0.07%-799.39K
Emerald advisers28.64K0.02%-782.56K
Orbimed advisors---764.60K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.51M0.00%1.51M$40.27M
Artisan partners limited partnership1.33M0.05%1.33M$29.65M
Vanguard fiduciary trust875.72K0.01%875.72K$19.49M
Balyasny asset management312.98K0.01%312.98K$6.97M
Stempoint capital lp242.57K1.05%242.57K$5.40M

Sold Out

HolderChange
Coppell advisory solutions-4.00
Bear mountain capital-7.00
Concord wealth partners-10.00
Financial consulate-10.00
Advisornet financial-12.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026285-18.10%93,214,952-43.97%550.57%127-25.73%102-15.70%
Dec 31, 2025107-69.69%24,070,676-85.64%140.14%52-72.92%38-64.15%
Sep 30, 2025134-59.02%29,202,139-82.81%170.17%67-54.73%41-66.94%
Jun 30, 2025321-3.02%169,479,977-1.03%1000.96%143-12.80%12318.27%
Mar 31, 20253298.94%171,281,5815.19%1021.07%163-8.94%10341.10%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF7.63M4.46%1.69K
Vanguard Total Stock Mkt Idx Inv4.04M2.37%26.05K
Vanguard US Total Market Shares ETF3.89M2.33%4.42K
State Street® SPDR® S&P® Biotech ETF3.80M2.22%-37.63K
First Trust NYSE Arca Biotech ETF3.01M1.77%-
Vanguard Small Cap Index2.95M1.73%67.55K
iShares Russell 2000 ETF2.96M1.73%25.00K
Vanguard Small Cap Growth Index Inv1.65M0.97%47.65K
SPDR® S&P Biotech ETF1.54M0.91%3.42K
Vanguard Institutional Extnd Mkt Idx Tr1.40M0.82%34.45K

Recent Insider Transactions

DateNameRoleActivityValue
May 04, 2026Kihara James PRINCIPAL ACCOUNTING OFFICERSell$29.02K
May 04, 2026Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICERSell$76.40K
Apr 07, 2026Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICERSell$60.14K
Apr 07, 2026Kihara James PRINCIPAL ACCOUNTING OFFICERSell$22.87K
Mar 25, 2026Owen Adams Catherine Chief Executive OfficerSell$249.93K

Insider Transactions Trends

DateBuySell
2026 Q2-4
2026 Q1-10
2025 Q4-3
2025 Q3-3
2025 Q2-8

ACAD Ownership FAQ

Who Owns ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals shareholders are primarily institutional investors at 55.05%, followed by 0.33% insiders and 44.62% retail investors. The average institutional ownership in ACADIA Pharmaceuticals's industry, Biotech Stocks , is 34.83%, which ACADIA Pharmaceuticals exceeds.

Who owns the most shares of ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals’s largest shareholders are Baker bros. advisors lp (42.9M shares, 25.33%), Blackrock funding, inc. /de (21.55M shares, 12.73%), and Vanguard group (15.15M shares, 8.98%). Together, they hold 47.03% of ACADIA Pharmaceuticals’s total shares outstanding.

Does Blackrock own ACADIA Pharmaceuticals?

Yes, BlackRock owns 7.32% of ACADIA Pharmaceuticals, totaling 12.06M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 196.01M$. In the last quarter, BlackRock increased its holdings by 393.47K shares, a 3.37% change.

Who is ACADIA Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is ACADIA Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 9.78% of its assets in 2.87M ACADIA Pharmaceuticals shares, valued at 63.95M$.

Who is the top mutual fund holder of ACADIA Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ACADIA Pharmaceuticals shares, with 4.46% of its total shares outstanding invested in 7.63M ACADIA Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools